Related references
Note: Only part of the references are listed.Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
Madhav Subramanian et al.
CELL REPORTS MEDICINE (2023)
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer
Ilkka Liikanen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma
Thomas Denize et al.
CLINICAL CANCER RESEARCH (2022)
Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma
Sonia Simonetti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
DNA Polymerase Delta 1 Catalytic Subunit (POLD1) as a Prognostic Factor in Clear Cell Renal Cell Carcinoma Patients
Janusz Godlewski et al.
IN VIVO (2022)
Ferroptosis: machinery and regulation
Xin Chen et al.
AUTOPHAGY (2021)
Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells
Yahui Ding et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma et al.
CELL METABOLISM (2021)
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Philip S. Robinson et al.
NATURE GENETICS (2021)
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Underappreciated Roles of DNA Polymerase δ in Replication Stress Survival
Jeannette Fuchs et al.
TRENDS IN GENETICS (2021)
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Sophie M. Poznanski et al.
CELL METABOLISM (2021)
Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma
Xiaohui Wu et al.
FRONTIERS IN GENETICS (2021)
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
Sarah K. Whiteside et al.
IMMUNOLOGY (2021)
Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
Shuai Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop
Francesco Marangoni et al.
CELL (2021)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity
Chengxian Xu et al.
CELL REPORTS (2021)
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor
Junjun He et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The immunology of renal cell carcinoma
C. Marcela Diaz-Montero et al.
NATURE REVIEWS NEPHROLOGY (2020)
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer et al.
CANCER CELL (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
Charles S. Tannenbaum et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types
Feng Wang et al.
JAMA ONCOLOGY (2019)
Mechanisms Controlling PD-L1 Expression in Cancer
Jong-Ho Cha et al.
MOLECULAR CELL (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1)
Yifang Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
GSCALite: a web server for gene set cancer analysis
Chun-Jie Liu et al.
BIOINFORMATICS (2018)
High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
Andreas Seeber et al.
CANCER SCIENCE (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
Shan Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
Single-cell RNA sequencing to explore immune cell heterogeneity
Efthymia Papalexi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
Yana G. Najjar et al.
CLINICAL CANCER RESEARCH (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Functions of CD40 and Its Ligand, gp39 (CD40L)
Jon D. Leman et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2017)
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Matthew G. Rees et al.
NATURE CHEMICAL BIOLOGY (2016)
POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies
Emmanuelle Nicolas et al.
GENE (2016)
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma
Alejo Rodriguez-Vida et al.
ESMO OPEN (2016)
A panoply of errors: polymerase proofreading domain mutations in cancer
Emily Rayner et al.
NATURE REVIEWS CANCER (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero et al.
ONCOTARGET (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
Claire Palles et al.
NATURE GENETICS (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
DNA polymerase delta in dna replication and genome maintenance
Marc J. Prindle et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Purinergic P2X7 Receptors Participate in Disturbed Intracellular Calcium Homeostasis in Peripheral Blood Mononuclear Cells of Patients with Chronic Kidney Disease
Ingrid Lajdova et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
Yoshihiro Komohara et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Jennifer S. Ko et al.
CANCER RESEARCH (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Significance of DNA Polymerase Delta Catalytic Subunit p125 Induced by Mutant p53 in the Invasive Potential of Human Hepatocellular Carcinoma
Kensaku Sanefuji et al.
ONCOLOGY (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
CD56bright natural killer (NK) cells: an important NK cell subset
Aurelie Poli et al.
IMMUNOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
DNA damage alters DNA polymerase to a form that exhibits increased discrimination against modified template bases and mismatched primers
Xiao Meng et al.
NUCLEIC ACIDS RESEARCH (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Share Paper
